Seung Hae Kwon

TL;DR: Given such favorable properties including low toxicity, biocompatibility, and fast uptake by several nondestructive endocytic pathways, the HGC nanoparticles may serve as a versatile carrier for the intracellular delivery of therapeutic agents.

TL;DR: The development of new nanoscale drug carriers, chitosan-based nanoparticles (CNPs) that could encapsulate a photosensitizer, protophorphyrin IX (PpIX), and deliver it to tumor tissue and results indicate that PpIX-CNPs have potential as an effective drug delivery system for clinical photodynamic therapy.

TL;DR: A facile and universal cell surface modification method that involves mild reduction of disulfide bonds in cell membrane protein to thiol groups facilitates enhanced cellular activities in mice, overcoming immune rejection.

TL;DR: In vitro studies showed that SR-A targetable and photoactivatable Ce6/DS-DOCA nanoagents with more selective targeting to the activated macrophages will have great potential for treatment of inflammatory diseases.

TL;DR: From in vivo fluorescence imaging study, it is found that the MSA modified np-Au NPs efficiently worked for controlled release of doxorubicin with light initiation in a mouse.